Tag: Association of the British Pharmaceutical Industry
UK life sciences failing to reach its potential despite high R&D investment, new report reveals
Wes Streeting recently announced his plans to bolster the economy through the life sciences sector
“The UK remains genuinely world-leading for life sciences in...
ABPI outlines top priorities for Labour’s first 100 days in office
ABPI calls on Labour to urgently appoint a new Chair and Chief Executive to the Medicines and Healthcare products Regulatory Agency (MHRA)
The Association of...
UK launches Critical Imports Council to secure supplies of medicines, smartphone chips
The Council aims to address the supply challenges businesses face and develop real-life solutions
The UK government has intensified efforts to safeguard supplies of...
Over 100 medicines are currently in short supply, warns BGMA
Reducing disruptions to the movement of medicines around the world is “absolutely critical” for maintaining supply resilience in the UK, ABPI has suggested.
The...
DHSC publishes 2024 Voluntary Scheme agreement text
The new VPAG scheme will save the NHS £14 billion over five years in medicines costs
The Department of Health and Social Care (DHSC)...
New VPAG scheme to save NHS £14 billion
The level of annual allowed growth in sales of branded medicines will double from two per cent per year in 2024 to four per...